Cargando…
Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly transmissible and has caused a pandemic named coronavirus disease 2019 (COVID-19), which has quickly spread worldwide. Although several therapeutic agents have been evaluated or approved for the treatment of COVID-19...
Autores principales: | Yan, Gangan, Li, Dongsheng, Lin, Yuan, Fu, Zhenghao, Qi, Haiyan, Liu, Xiaoping, Zhang, Jing, Si, Shuyi, Chen, Yunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645223/ https://www.ncbi.nlm.nih.gov/pubmed/34865653 http://dx.doi.org/10.1186/s13578-021-00720-3 |
Ejemplares similares
-
Protocol for high-throughput screening of SARS-CoV-2 main protease inhibitors using a robust fluorescence polarization assay
por: Zhang, Jing, et al.
Publicado: (2022) -
A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors
por: Yan, Haohao, et al.
Publicado: (2022) -
Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease
por: Li, Dongsheng, et al.
Publicado: (2022) -
A miniaturized sandwich immunoassay platform for the detection of protein-protein interactions
por: Liu, Qiongming, et al.
Publicado: (2010) -
A simple fluorescence based assay for quantification of human immunodeficiency virus particle release
por: Hermle, Johannes, et al.
Publicado: (2010)